CK Life Sciences International Overview

  • Founded
  • 2000
  • Status
  • Public
  • Employees
  • 1,773
  • Stock Symbol
  • 00775
Stock Symbol
  • Investments
  • 13
  • Share Price
  • $0.12
  • (As of Friday Closing)

CK Life Sciences International General Information


CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research and development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a global presence that spans North America and Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 2 Dai Fu Street
  • Tai Po Industrial Estate
  • Hong Kong
  • Hong Kong
+852 2126 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CK Life Sciences International Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.12 $0.12 $0.08 - $0.15 $1.12B 9.6B 8.55M

CK Life Sciences International Financials Summary

In Thousands,
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,784,244 1,661,962 947,680 1,195,027
Revenue 609,366 633,900 667,658 602,237
EBITDA 40,510 74,114 87,932 72,085
Net Income 12,562 23,193 33,555 33,159
Total Assets 1,384,136 1,375,676 1,332,698 1,354,603
Total Debt 753,986 722,932 614,983 588,264
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CK Life Sciences International Executive Team (2)

Name Title Board Seat Contact Info
Kam Lam Chief Executive Officer, President, Executive Director & Member of Nomination Committee
Ying Choi Yu Vice President, Chief Executive Officer, Executive Director and Compliance Officer
To view CK Life Sciences International’s complete executive team members history, request access »

CK Life Sciences International Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CK Life Sciences International Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 00000000 01-Dec-2018 000000000 00000 00 Buildings and Property
00000000 16-Nov-2017 000000000000000000 Drug Delivery
0000000 0000000000 01-Jan-2014 000000000000000000 Distributors/Wholesale
00000000 0000 29-Nov-2012 000000000000000000 00000 Food Products 000 000
Peaty Trading Group 04-Jan-2012 Merger/Acquisition 000.00 Distributors/Wholesale (B2C)
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

CK Life Sciences International Subsidiaries (5)

Company Name Industry Location Founded
Polynoma Drug Delivery San Diego, CA 2007
0000 0000000000000 Pharmaceuticals Minto, Australia 0000
0000000 0000000000 Distributors/Wholesale Adelaide, Australia 0000
000 00000000000000 Drug Delivery Vancouver, Canada 0000
00000000 0000 Food Products Melbourne, Australia 0000
To view CK Life Sciences International’s complete subsidiaries history, request access »